CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Q3) - USD ($)
$ in Thousands |
Total |
Common Class A |
Common Stock |
Common Stock
Common Class A
|
Additional paid-in capital |
Accumulated deficit |
| Beginning balance (in shares) at Dec. 31, 2021 |
|
|
|
1,624,236
|
|
|
| Beginning balance at Dec. 31, 2021 |
$ 131,888
|
|
|
$ 0
|
$ 340,571
|
$ (208,683)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
43,699
|
|
|
| Issuance of common stock upon exercise of stock options |
574
|
|
|
|
574
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
15,741
|
|
|
| Issuance of common stock upon purchase of ESPP (in shares) |
|
|
3,308
|
|
|
|
| Issuance of common stock upon purchase of ESPP |
271
|
|
|
|
271
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange (in shares) |
|
|
|
(3,723)
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange |
(331)
|
|
|
|
(331)
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
11,649
|
|
|
|
11,649
|
|
| Net loss |
(95,444)
|
|
|
|
|
(95,444)
|
| Ending balance (in shares) at Dec. 31, 2022 |
|
1,688,824
|
|
1,688,824
|
|
|
| Ending balance at Dec. 31, 2022 |
38,607
|
|
|
$ 0
|
342,734
|
(304,127)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
7,406
|
|
|
| Issuance of common stock upon exercise of stock options |
92
|
|
|
|
92
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
15,336
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange (in shares) |
|
|
|
(2,498)
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange |
(60)
|
|
|
|
(60)
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
1,720
|
|
|
|
1,720
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares) |
|
|
|
187,920
|
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs |
9,300
|
|
|
|
9,300
|
|
| Issuance of common stock for consulting services (in shares) |
|
|
|
2,700
|
|
|
| Issuance of common stock for consulting services |
112
|
|
|
|
112
|
|
| Net loss |
(20,825)
|
|
|
|
|
(20,825)
|
| Ending balance (in shares) at Mar. 31, 2023 |
|
|
|
1,899,688
|
|
|
| Ending balance at Mar. 31, 2023 |
28,946
|
|
|
$ 0
|
353,898
|
(324,952)
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
1,688,824
|
|
1,688,824
|
|
|
| Beginning balance at Dec. 31, 2022 |
38,607
|
|
|
$ 0
|
342,734
|
(304,127)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(54,819)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
|
|
2,700,909
|
|
|
| Ending balance at Sep. 30, 2023 |
4,292
|
|
|
$ 0
|
363,238
|
(358,946)
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
1,688,824
|
|
1,688,824
|
|
|
| Beginning balance at Dec. 31, 2022 |
$ 38,607
|
|
|
$ 0
|
342,734
|
(304,127)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options (in shares) |
10,081
|
|
|
10,081
|
|
|
| Issuance of common stock upon exercise of stock options |
$ 130
|
|
|
|
130
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
42,741
|
|
|
| Issuance of common stock upon purchase of ESPP (in shares) |
|
|
3,131
|
|
|
|
| Issuance of common stock upon purchase of ESPP |
33
|
|
|
|
33
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange (in shares) |
|
|
|
(4,899)
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange |
(88)
|
|
|
|
(88)
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
8,480
|
|
|
|
8,480
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares) |
|
|
|
687,920
|
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs |
16,952
|
|
|
|
16,952
|
|
| Issuance of common stock upon exercise of pre-funded warrants (in shares) |
|
|
|
2,216,349
|
|
|
| Issuance of common stock for consulting services (in shares) |
|
|
|
2,700
|
|
|
| Issuance of common stock for consulting services |
112
|
|
|
|
112
|
|
| Common stock issued in connection with reverse stock split (in shares) |
|
|
|
59,801
|
|
|
| Net loss |
(68,920)
|
|
|
|
|
(68,920)
|
| Ending balance (in shares) at Dec. 31, 2023 |
|
8,283,865
|
|
8,283,865
|
|
|
| Ending balance at Dec. 31, 2023 |
3,187
|
|
|
$ 0
|
376,234
|
(373,047)
|
| Beginning balance (in shares) at Mar. 31, 2023 |
|
|
|
1,899,688
|
|
|
| Beginning balance at Mar. 31, 2023 |
28,946
|
|
|
$ 0
|
353,898
|
(324,952)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
2,648
|
|
|
| Issuance of common stock upon exercise of stock options |
38
|
|
|
|
38
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
9,440
|
|
|
| Issuance of common stock upon purchase of ESPP (in shares) |
|
|
2,131
|
|
|
|
| Issuance of common stock upon purchase of ESPP |
31
|
|
|
|
31
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
2,577
|
|
|
|
2,577
|
|
| Issuance of common stock upon exercise of pre-funded warrants (in shares) |
|
|
|
43,401
|
|
|
| Net loss |
(18,835)
|
|
|
|
|
(18,835)
|
| Ending balance (in shares) at Jun. 30, 2023 |
|
|
|
1,957,308
|
|
|
| Ending balance at Jun. 30, 2023 |
12,757
|
|
|
$ 0
|
356,544
|
(343,787)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options (in shares) |
|
|
|
27
|
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
12,891
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange (in shares) |
|
|
|
(2,066)
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange |
(27)
|
|
|
|
(27)
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
2,156
|
|
|
|
2,156
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares) |
|
|
|
210,000
|
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs |
4,565
|
|
|
|
4,565
|
|
| Issuance of common stock upon exercise of pre-funded warrants (in shares) |
|
|
|
462,948
|
|
|
| Common stock issued in connection with reverse stock split (in shares) |
|
|
|
59,801
|
|
|
| Net loss |
(15,159)
|
|
|
|
|
(15,159)
|
| Ending balance (in shares) at Sep. 30, 2023 |
|
|
|
2,700,909
|
|
|
| Ending balance at Sep. 30, 2023 |
4,292
|
|
|
$ 0
|
363,238
|
(358,946)
|
| Ending balance (in shares) at Dec. 31, 2023 |
|
8,283,865
|
|
8,283,865
|
|
|
| Ending balance at Dec. 31, 2023 |
3,187
|
|
|
$ 0
|
376,234
|
(373,047)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Issuance of common stock upon vesting of RSUs (in shares) |
|
|
|
36,570
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange (in shares) |
|
|
|
(5,937)
|
|
|
| Share repurchase related to Section 16 Officer tax coverage exchange |
(3)
|
|
|
|
(3)
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
1,443
|
|
|
|
1,443
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs (in shares) |
|
|
|
2,220,000
|
|
|
| Issuance of common stock and related warrants in registered offering, net of issuance costs |
7,171
|
|
|
|
7,171
|
|
| Issuance of common stock upon exercise of pre-funded warrants (in shares) |
|
|
|
6,091,280
|
|
|
| Net loss |
(8,313)
|
|
|
|
|
(8,313)
|
| Ending balance (in shares) at Mar. 31, 2024 |
|
|
|
16,625,778
|
|
|
| Ending balance at Mar. 31, 2024 |
3,485
|
|
|
$ 0
|
384,845
|
(381,360)
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
8,283,865
|
|
8,283,865
|
|
|
| Beginning balance at Dec. 31, 2023 |
3,187
|
|
|
$ 0
|
376,234
|
(373,047)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Net loss |
(23,087)
|
|
|
|
|
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
21,625,778
|
|
21,625,778
|
|
|
| Ending balance at Sep. 30, 2024 |
(5,404)
|
|
|
$ 0
|
390,730
|
(396,134)
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
16,625,778
|
|
|
| Beginning balance at Mar. 31, 2024 |
3,485
|
|
|
$ 0
|
384,845
|
(381,360)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
1,735
|
|
|
|
1,735
|
|
| Net loss |
(7,016)
|
|
|
|
|
(7,016)
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
|
16,625,778
|
|
|
| Ending balance at Jun. 30, 2024 |
(1,796)
|
|
|
$ 0
|
386,580
|
(388,376)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
| Stock-based compensation - stock options, RSAs, RSUs |
1,707
|
|
|
|
1,707
|
|
| Issuance of pre-funded warrants and warrants in private placement, net of issuance costs |
2,443
|
|
|
|
2,443
|
|
| Issuance of common stock upon exercise of pre-funded warrants (in shares) |
|
|
|
5,000,000
|
|
|
| Net loss |
(7,758)
|
|
|
|
|
(7,758)
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
21,625,778
|
|
21,625,778
|
|
|
| Ending balance at Sep. 30, 2024 |
$ (5,404)
|
|
|
$ 0
|
$ 390,730
|
$ (396,134)
|